We narrowed to 18,241 results for: RET

#132112

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 21, 2019

Industry, Academic Institutions, and Nonprofits

#161291

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#149311

Gateway-compatible Entry vector, with insert of NSP8 gene's CDS from SARS-CoV-2 isolate Wuhan-Hu-1. Does not contain stop codon.

Fritz Roth

Kim et al G3 (Bethesda). 2020 Aug 6. pii: g3.120.4

May 6, 2020

Industry, Academic Institutions, and Nonprofits

#111392

AAV vector with hSynapsin promoter, Cre-OFF hCAR (for efficient CAV-2 infection), Cre-ON ChETA-EYFP (for optogenetic activation), and W3SL regulatory cassette (for maximize cloning capacity)

Adam Kepecs

Li et al Neuron. 2018 Jun 6;98(5):905-917.e5. doi

June 7, 2018

Academic Institutions and Nonprofits only

#161046

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#178065

Expression of WLS-HA protein (R536C mutant)

Joseph Gleeson

Chai et al N Engl J Med. 2021 Sep 30;385(14):1292-1

Jan. 10, 2022

Academic Institutions and Nonprofits only